Phibro Animal Health Statistics
Total Valuation
PAHC has a market cap or net worth of $1.61 billion. The enterprise value is $2.30 billion.
| Market Cap | 1.61B |
| Enterprise Value | 2.30B |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025, after market close.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Sep 3, 2025 |
Share Statistics
PAHC has 40.53 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Current Share Class | 20.37M |
| Shares Outstanding | 40.53M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 50.07% |
| Owned by Institutions (%) | 51.59% |
| Float | 20.21M |
Valuation Ratios
The trailing PE ratio is 33.29 and the forward PE ratio is 15.06. PAHC's PEG ratio is 1.00.
| PE Ratio | 33.29 |
| Forward PE | 15.06 |
| PS Ratio | 1.24 |
| Forward PS | n/a |
| PB Ratio | 5.62 |
| P/TBV Ratio | 8.47 |
| P/FCF Ratio | 38.39 |
| P/OCF Ratio | 20.04 |
| PEG Ratio | 1.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.93, with an EV/FCF ratio of 54.94.
| EV / Earnings | 47.62 |
| EV / Sales | 1.77 |
| EV / EBITDA | 12.93 |
| EV / EBIT | 17.21 |
| EV / FCF | 54.94 |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 2.70.
| Current Ratio | 2.76 |
| Quick Ratio | 1.04 |
| Debt / Equity | 2.70 |
| Debt / EBITDA | 4.03 |
| Debt / FCF | 18.43 |
| Interest Coverage | 3.79 |
Financial Efficiency
Return on equity (ROE) is 17.80% and return on invested capital (ROIC) is 9.05%.
| Return on Equity (ROE) | 17.80% |
| Return on Assets (ROA) | 7.13% |
| Return on Invested Capital (ROIC) | 9.05% |
| Return on Capital Employed (ROCE) | 12.51% |
| Revenue Per Employee | $523,723 |
| Profits Per Employee | $19,501 |
| Employee Count | 2,475 |
| Asset Turnover | 1.11 |
| Inventory Turnover | 2.51 |
Taxes
In the past 12 months, PAHC has paid $19.73 million in taxes.
| Income Tax | 19.73M |
| Effective Tax Rate | 29.02% |
Stock Price Statistics
The stock price has increased by +93.74% in the last 52 weeks. The beta is 0.88, so PAHC's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +93.74% |
| 50-Day Moving Average | 31.80 |
| 200-Day Moving Average | 24.64 |
| Relative Strength Index (RSI) | 68.69 |
| Average Volume (20 Days) | 400,758 |
Short Selling Information
The latest short interest is 931,181, so 2.30% of the outstanding shares have been sold short.
| Short Interest | 931,181 |
| Short Previous Month | 1.10M |
| Short % of Shares Out | 2.30% |
| Short % of Float | 4.61% |
| Short Ratio (days to cover) | 2.97 |
Income Statement
In the last 12 months, PAHC had revenue of $1.30 billion and earned $48.26 million in profits. Earnings per share was $1.19.
| Revenue | 1.30B |
| Gross Profit | 405.62M |
| Operating Income | 133.56M |
| Pretax Income | 25.95M |
| Net Income | 48.26M |
| EBITDA | 177.75M |
| EBIT | 133.56M |
| Earnings Per Share (EPS) | $1.19 |
Balance Sheet
The company has $78.48 million in cash and $770.91 million in debt, giving a net cash position of -$692.43 million or -$17.08 per share.
| Cash & Cash Equivalents | 78.48M |
| Total Debt | 770.91M |
| Net Cash | -692.43M |
| Net Cash Per Share | -$17.08 |
| Equity (Book Value) | 285.68M |
| Book Value Per Share | 7.05 |
| Working Capital | 517.13M |
Cash Flow
In the last 12 months, operating cash flow was $80.12 million and capital expenditures -$38.29 million, giving a free cash flow of $41.83 million.
| Operating Cash Flow | 80.12M |
| Capital Expenditures | -38.29M |
| Free Cash Flow | 41.83M |
| FCF Per Share | $1.03 |
Margins
Gross margin is 31.29%, with operating and profit margins of 10.30% and 3.72%.
| Gross Margin | 31.29% |
| Operating Margin | 10.30% |
| Pretax Margin | 5.25% |
| Profit Margin | 3.72% |
| EBITDA Margin | 13.71% |
| EBIT Margin | 10.30% |
| FCF Margin | 3.23% |
Dividends & Yields
This stock pays an annual dividend of $0.48, which amounts to a dividend yield of 1.21%.
| Dividend Per Share | $0.48 |
| Dividend Yield | 1.21% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 40.34% |
| Buyback Yield | -0.38% |
| Shareholder Yield | 0.83% |
| Earnings Yield | 3.01% |
| FCF Yield | 2.60% |
Analyst Forecast
The average price target for PAHC is $27.50, which is -30.59% lower than the current price. The consensus rating is "Hold".
| Price Target | $27.50 |
| Price Target Difference | -30.59% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PAHC has an Altman Z-Score of 2.5 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.5 |
| Piotroski F-Score | 6 |